Cytek Investor Presentation Deck
Acquisition of Luminex's Flow Cytometry and Imaging Business¹
provides key strategic benefits
1
Enhances technical
capabilities
Enhanced Al-driven analytical
performance from high-
resolution cell imagery
CYTEK
TRANSCEND THE CONVENTIONAL
Capillary micro fluidics allows
for reduced cost of goods,
higher gross margins and
improved ease of use
(1) Acquisition closed February 28, 2023
2
Expands customer base
and commercial reach
7,000+
Units Placed
70+
Countries
1,500+
Customers
Expect replacement upgrades
to Northern Lights and Aurora
platforms
3
Significant operational
synergies across service
Quicker access by field
personnel
More effective and efficient
Service / Support
Enables future expansion of
service gross margins
Positions Cytek for future
clinical expansion
6View entire presentation